Evidence map›Paper›PMID 32419519›Full record

ReviewJournal of enzyme inhibition and medicinal chemistry2020

Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design.

Lidia Ciccone, Nicoló Tonali, Susanna Nencetti, Elisabetta Orlandini

Open access · goldAbstract readReview
In one paragraph

Review in Journal of enzyme inhibition and medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Special Issue "Advances in Drug Discovery and Synthesis".International journal of molecular sciences · 2025
    Article
  3. Article
  4. A Snapshot of the Most Recent Transthyretin Stabilizers.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Lidia CicconeDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID http://orcid.org/0000-0002-2762-1929
Nicoló TonaliCNRS, Université Paris-Saclay, Châtenay-Malabry, France.
Susanna NencettiDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Elisabetta OrlandiniDepartment of Earth Sciences, University of Pisa, Pisa, Italy.
University of Pisa · ITCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural compounds, such as plant and fruit extracts have shown neuroprotective effect against neurodegenerative diseases. It has been reported that several natural compounds binding to transthyretin (TTR) can be useful in amyloidosis prevention. TTR is a transporter protein that under physiological condition carries thyroxine (T

Indexed as

Drug DesignAmyloidAmyloid Neuropathies, FamilialHumansNeuroprotective AgentsPrealbuminAmyloidNeuroprotective AgentsPrealbumindrug discoveryNatural compoundsneuroprotectiontransthyretin amyloid diseasesX-ray structure analysis

Identifiers

PMID32419519
PMCPMC7301710
OpenAlexW3028423921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.